Why the study?
Does the coexistence of Factor V Leiden and Factor II A20210 mutations increase the rate of recurrent venous thromboembolism in patients with deep venous thrombosis?
Population
542 patients with a documented diagnosis of deep venous thrombosis in one leg consecutively referred for a…
Comparison
Carriers of both Factor V Leiden and Factor II… vs Subjects carrying neither mutation, or carriers…
Design
Cohort
Loading...
May identify high-risk DVT patients; leaves open whether genotyping should guide anticoagulation duration.
Does the coexistence of Factor V Leiden and Factor II A20210 mutations increase the rate of recurrent venous thromboembolism in patients with deep venous thrombosis?
Patients carrying both Factor V Leiden and Factor II A20210 mutations have a significantly higher rate of recurrent venous thromboembolism, comparable to subjects with deficiencies of natural anticoagulant proteins.
A 1999 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: